ConcertAI Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Employees
-
500
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
4
- Investments
-
2
ConcertAI General Information
Description
Developer of medical research tool suite intended to design and deliver care-based oncology research and data analytics. The company's suite specializes in oncology health outcomes and clinical trial efficiency research using custom patient surveys to help pharmaceutical companies evaluate currently approved treatments and develop new treatments, enabling project teams, medical experts, and scientists to design and deliver projects generating real-world evidence and insight.
Contact Information
Website
www.concertai.com(Operating Subsidiary)
Corporate Office
- 1120 Massachusetts Avenue
- Cambridge, MA 02138
- United States
Corporate Office
- 1120 Massachusetts Avenue
- Cambridge, MA 02138
- United States
ConcertAI Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
ConcertAI Comparisons
Industry
Financing
Details
ConcertAI Competitors (10)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
COTA | Private Equity-Backed | New York, NY | ||||
TriNetX | Private Equity-Backed | Cambridge, MA | ||||
Syapse | Venture Capital-Backed | San Francisco, CA | ||||
Flatiron | Formerly VC-backed | New York, NY | ||||
Aetion | Venture Capital-Backed | New York, NY |
ConcertAI Patents
ConcertAI Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220138585-A1 | Systems and methods for applying a lens function generated using supervised learning techniques to segment data provided to an unsupervised learning model | Pending | 30-Oct-2020 | ||
EP-4238013-A1 | Systems and methods for applying a lens function generated using supervised learning techniques to segment data provided to an unsupervised learning model | Pending | 30-Oct-2020 | ||
EP-4238013-A4 | Systems and methods for applying a lens function generated using supervised learning techniques to segment data provided to an unsupervised learning model | Pending | 30-Oct-2020 | G06N3/088 |
ConcertAI Executive Team (18)
Name | Title | Board Seat |
---|---|---|
Jeffrey Elton Ph.D | Chief Executive Officer & Board Member | |
Pyeush Gurha | Chief Technology Officer | |
Jitendra Gupta | Managing Director, ConcertAI India | |
Lauren Gordon | Chief People Officer | |
Claudio D'Ambrosio | Chief Revenue Officer |
ConcertAI Board Members (7)
Name | Representing | Role | Since |
---|---|---|---|
Sixth Street Partners | Board Member | ||
ConcertAI | Board Observer | ||
Declaration Partners | Board Member | ||
ConcertAI | Chief Executive Officer & Board Member | ||
Self | Executive Chairman |
ConcertAI Signals
ConcertAI Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
ConcertAI Acquisitions (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
CancerLinQ | 11-Dec-2023 | Decision/Risk Analysis | |||
TeraRecon | 09-Nov-2021 | Merger/Acquisition | Diagnostic Equipment |
ConcertAI Subsidiaries (2)
Company Name | Industry | Location | Founded |
---|---|---|---|
CancerLinQ | Decision/Risk Analysis | Alexandria, VA | 2013 |
TeraRecon | Diagnostic Equipment | Durham, NC |
ConcertAI FAQs
-
When was ConcertAI founded?
ConcertAI was founded in 2002.
-
Who is the founder of ConcertAI?
Brigham Hyde Ph.D is the founder of ConcertAI.
-
Who is the CEO of ConcertAI?
Jeffrey Elton Ph.D is the CEO of ConcertAI.
-
Where is ConcertAI headquartered?
ConcertAI is headquartered in Cambridge, MA.
-
What is the size of ConcertAI?
ConcertAI has 500 total employees.
-
What industry is ConcertAI in?
ConcertAI’s primary industry is Discovery Tools (Healthcare).
-
Is ConcertAI a private or public company?
ConcertAI is a Private company.
-
What is the current valuation of ConcertAI?
The current valuation of ConcertAI is
. -
What is ConcertAI’s current revenue?
The current revenue for ConcertAI is
. -
How much funding has ConcertAI raised over time?
ConcertAI has raised $300M.
-
Who are ConcertAI’s investors?
Baptist Health has invested in ConcertAI.
-
Who are ConcertAI’s competitors?
COTA, TriNetX, Syapse, Flatiron, and Aetion are some of the 10 competitors of ConcertAI.
-
When was ConcertAI acquired?
ConcertAI was acquired on 29-Mar-2022.
-
Who acquired ConcertAI?
ConcertAI was acquired by SymphonyAI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »